Total Payments
$9,225
2024 Payments
$654.44
Companies
39
Transactions
427
Medicare Patients
1,177
Medicare Billing
$137,165
Payment Breakdown by Category
Food & Beverage$9,195 (99.7%)
Education$30.50 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,195 | 423 | 99.7% |
| Education | $30.50 | 4 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,514 | 66 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,211 | 67 | $0 (2022) |
| Novo Nordisk Inc | $1,130 | 56 | $0 (2024) |
| Lilly USA, LLC | $611.85 | 17 | $0 (2024) |
| ABBVIE INC. | $610.86 | 21 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $521.33 | 24 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $472.09 | 29 | $0 (2019) |
| GlaxoSmithKline, LLC. | $442.98 | 21 | $0 (2024) |
| Allergan Inc. | $409.36 | 17 | $0 (2019) |
| Bayer Healthcare Pharmaceuticals Inc. | $402.85 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $654.44 | 33 | AstraZeneca Pharmaceuticals LP ($202.86) |
| 2023 | $614.68 | 22 | AstraZeneca Pharmaceuticals LP ($285.92) |
| 2022 | $936.98 | 37 | Novo Nordisk Inc ($283.96) |
| 2021 | $900.08 | 42 | AbbVie Inc. ($229.94) |
| 2020 | $147.05 | 10 | AstraZeneca Pharmaceuticals LP ($53.85) |
| 2019 | $1,139 | 56 | AstraZeneca Pharmaceuticals LP ($321.30) |
| 2018 | $2,144 | 96 | Lilly USA, LLC ($396.31) |
| 2017 | $2,689 | 131 | Janssen Pharmaceuticals, Inc ($589.88) |
All Payment Transactions
427 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: DIABETES | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Respiratory | ||||||
| 09/11/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Cardio-renal | ||||||
| 07/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $36.48 | General |
| Category: Respiratory | ||||||
| 07/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Respiratory | ||||||
| 07/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: DIABETES | ||||||
| 07/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: Cardio-renal | ||||||
| 07/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: RESPIRATORY | ||||||
| 06/20/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Diabetes | ||||||
| 06/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: DIABETES | ||||||
| 06/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/29/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Biological | ||||||
| 05/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Respiratory | ||||||
| 05/14/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.51 | General |
| Category: PSYCHIATRY | ||||||
| 05/09/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Oncology | ||||||
| 04/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Respiratory | ||||||
| 03/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Cardio-renal | ||||||
| 03/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Inflammation | ||||||
| 03/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug), FARXIGA | Food and Beverage | In-kind items and services | $37.80 | General |
| Category: Respiratory | ||||||
| 02/28/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Diabetes | ||||||
| 02/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 167 | 566 | $43,180 | $30,954 |
| 2022 | 9 | 248 | 683 | $46,992 | $34,703 |
| 2021 | 13 | 337 | 925 | $58,606 | $40,179 |
| 2020 | 14 | 425 | 778 | $50,355 | $31,329 |
Total Patients
1,177
Total Services
2,952
Medicare Billing
$137,165
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 64 | 172 | $20,640 | $14,683 | 71.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 48 | 332 | $16,600 | $12,102 | 72.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 20 | 20 | $3,000 | $2,515 | 83.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $2,800 | $1,518 | 54.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 21 | 28 | $140.00 | $137.20 | 98.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 71 | 185 | $22,200 | $16,255 | 73.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 42 | 307 | $15,350 | $11,621 | 75.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 23 | 23 | $3,450 | $2,947 | 85.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $2,600 | $1,556 | 59.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 28 | $1,792 | $1,373 | 76.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 13 | 13 | $390.00 | $372.58 | 95.5% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2022 | 13 | 13 | $390.00 | $260.91 | 66.9% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 23 | 63 | $630.00 | $203.88 | 32.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 29 | 38 | $190.00 | $113.10 | 59.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 78 | 218 | $26,160 | $19,105 | 73.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 56 | 415 | $20,750 | $12,957 | 62.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 11 | 17 | $3,060 | $2,222 | 72.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 31 | 49 | $3,136 | $2,203 | 70.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 11 | 11 | $1,650 | $1,450 | 87.9% |
| 99439 | Chronic care management services, each additional 20 minutes of clinical staff time per calendar month | Office | 2021 | 15 | 28 | $1,120 | $833.86 | 74.5% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 15 | 15 | $310.00 | $273.75 | 88.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 15 | 15 | $300.00 | $273.75 | 91.3% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent | Office | 2021 | 13 | 13 | $390.00 | $258.83 | 66.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 13 | 13 | $390.00 | $215.67 | 55.3% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 25 | 62 | $620.00 | $203.36 | 32.8% |
About Dr. Jose Mole, MD
Dr. Jose Mole, MD is a Internal Medicine healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1629092283.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jose Mole, MD has received a total of $9,225 in payments from pharmaceutical and medical device companies, with $654.44 received in 2024. These payments were reported across 427 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($9,195).
As a Medicare-enrolled provider, Mole has provided services to 1,177 Medicare beneficiaries, totaling 2,952 services with total Medicare billing of $137,165. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Tampa, FL
- Active Since 07/27/2006
- Last Updated 01/13/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1629092283
Products in Payments
- FARXIGA (Drug) $1,070
- INVOKANA (Drug) $603.72
- XARELTO (Drug) $601.18
- Ozempic (Drug) $536.86
- ENTRESTO (Drug) $472.09
- VRAYLAR (Drug) $459.16
- TRULICITY (Drug) $431.61
- Kerendia (Drug) $402.85
- TOUJEO (Drug) $346.47
- Rybelsus (Drug) $250.79
- TRELEGY ELLIPTA (Drug) $219.27
- ELIQUIS (Drug) $196.83
- BREO (Drug) $172.73
- AIRSUPRA (Drug) $172.26
- BYDUREON (Drug) $165.37
- Vascepa (Drug) $160.94
- Victoza (Drug) $158.30
- LINZESS (Drug) $158.02
- EUFLEXXA (Device) $156.51
- Monarch Platform (Device) $147.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Tampa
Javier Pinilla-Ibarz, Md, MD
Internal Medicine — Payments: $1.9M
Internal Medicine $1.9M
Alberto Chiappori, Md, MD
Internal Medicine — Payments: $617,120
Internal Medicine $617,120
Ricardo Restrepo-Jaramillo, M.d, M.D
Internal Medicine — Payments: $562,511
Internal Medicine $562,511
Dr. Sady Alpizar, Md, MD
Internal Medicine — Payments: $509,824
Internal Medicine $509,824
Jhanelle Gray, Md, MD
Internal Medicine — Payments: $273,892
Internal Medicine $273,892
Dr. Andrew Kuykendall, M.d, M.D
Internal Medicine — Payments: $273,357
Internal Medicine $273,357